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In the bush and isolated areas of Africa, falci­
parum malaria is extremely difficult to diagnose, 
especially in the pernicious clinical presentation. 
Although the African states universally accept anti- 
malarial precautions, malaria is still a serious 
problem, especially where the intensity of in­
fection is hyperendemic and the rural medical 
services sparse and hospitals far removed. In 
Tropical Africa any acute fever of short duration 
may be malarial. (Gelfand, 1961).
The first infection with P. falciparum in infants 
born of immune mothers is generally associated 
with a low-grade parasitaemia and very mild 
clinical symptoms. (Gam-ham, 1949). This re­
sistance to malaria infection is mainly due to the 
passive transfer of protective antibodies from the 
mother, contained in the 7S gamma .globular frac­
tion (IgG) of the serum. After the age of six 
months (Cohen et al. 1961, Edozien, 1962) the 
inherited antibodies are exhausted and acquired 
immunity is only fully developed when the child 
is 4 to 5 years old.' During this period clinical 
effects are most severe and mortality is between 
5-15 per cent. By the fifth year, 70-80 per cent, 
of children in stable malaria areas harbour the 
parasites in their blood (Colbourne, 1954). 
Thereafter, and through adulthood, the diagnosis 
and even death from falciparum malaria becomes 
increasingly difficult to determine.
The cardinal features of malaria are periodic 
fever, splenomegaly and slight hepatomegaly, 
normocytic nomochronic anaemia and leukopenia 
(Hunter, 1966) but the indigenous African in 
West or East Africa has a relative homologous 
immunity to P. falciparum, and rarely shows 
these classical characteristics. This immunity de­
veloped is initially an acquisition of a tolerance to 
the infection, generally with a cessation of clinical
phenomena, despite persistence of parasitaemia, 
considerably in excess of initial clinical activity i n -  
childhood. Immunity depends on a persistent 
latent infection, but this- is strictly strain specific, 
the individual becoming refractory. He is, how­
ever, not immune to other strains of P. falciparum 
in other areas, often only 50-100 miles away. 
The severity and presentation of the infection, 
however, is frequently modified. Thus, malaria in 
Africa still has a high morbidity rate and is re­
sponsible for -more deaths than any other trans­
missible disease.
The certain diagnosis of active malaria is never 
easy among the “immunes” with chronic parasitae­
mia. Gametoyotes, ■ even if confirmed as P. 
falciparum, may be found months and even years 
after an overt, attack has subsided (Adams and 
Maegrai-th 1964). ■ .
The presence of trophozoits must be established, 
indicating the progress of an asexual cycle. Today, 
in clinical medicine, malaria is the greatest immi- 
tator amongst the “immunes” in Africa, often pre­
senting clinically resembling other conditions. For 
. instance, it may evoke a set of symptoms very 
similar to the acute surgical abdominal conditions 
such as appendicitis or peritonitis, or it may 
simulate pneumonis and pleurisy, especially in 
oases where -spontaneous splenic infarcts or sub- 
capsular haematomata have occurred.
The problem is how to diagnose and treat 
these malaria syndromes confidently with minimal 
' diagnostic errors. It is often difficult for the 
doctor to differentiate cases of malaria from 
several other similar conditions; how much more 
so for a nursing sister! A diagnostic error of mis­
sing malaria was usually disastrous. In hospital, 
with dootors and pathological services, diagnosis 
by delay and repeated blood smears and obser­
vation is possible, but in remote areas the 
standard thick and thin -stained smear for parasites 
alone, even if positive, is not always diagnostic.
T herapy
Strains of P. falciparum, chloroquine resistant, 
were first reported in two patients from the 
Magdalina Valley in Columbia (Moore and 
Lanier 1961). The fear of progressive outbreaks 
of resistant malignant tertian malaria developing, 
has been confirmed by resistant strains being re-
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ported in South America (Young, 1961), Brazil 
(Box 1963), Thailand (Young, 1962), Vietnam 
(Legters, 1965), and West Africa (Lasch, 1965). 
Drug resistance in malariology is defined as “the 
ability of a parasite strain to multiply or to sur­
vive in the presence of concentrations of a drug 
that normally destroys parasites of the same 
species, or prevents their multiplication” (W.H.O. 
1965).
Then, from February 1968, exciting advances 
in anti-malarial management began appearing in 
the medical literature with a new approach 
(Martin and Arnold, December 1967). They had 
proven that Trimethoprim (T.M.) a dihyrofolate 
reductase, had several advantages over pyrimetha­
mine as an anti-malarial against both normal and 
multi-drug resistant P. falciparum, as the proto­
zoa were sensitive to a deficiency of bile acid.
Now not only could the dose of trimethoprim 
be reduced, but it was unlikely that resistant 
strains of P. falciparum would develop to tri­
methoprim. In February 1968 the first trial of 
trimethoprim and Sulfalene combination as anti- 
malarials (Martin and Arnold 1968) seemed at 
last to hold out the hope of a one day treatment 
for malaria. This was further substantiated by the 
excellent proof of trimethoprim potentiating the 
effects of long-acting sulphonamides as anti- 
malarials (Bushby and Hitchings 1968) and the 
safe combination of trimethoprim (TM) and 
sulfamethoxozple (SMZ) administered for daily 
'periods from several months to two years 
(Kahn et al. 1968). At this time TM and SMZ, 
in the proportion of 1:5 became commercially 
available (Bactrim-Roche).
M e t h o d s
I devised the following single dose treatment 
for use as an unselected screening regimen for 
differentiating P. falciparum malarial infections 
presenting in a pernicious form from the other 
fevers in the tropics, often mistaken for malarial 
fever. The differentiation was simply by a 24-48 
hour therapeutic cure after the administration of 
a single dose of 10 tablets (Bactrim) containing 
a total dose of 800 mg trimethoprim and 4 gm of 
sulfamethoxazole. The patients, all African, were 
seen on an outpatient basis, and they all 'lived 
in the coastal belt of Southern Mocambique near 
the Zululand border. After blood smears had 
been taken, they were given 10 tablets as a single 
dose which were swallowed in the sister’s 
presence. Thereafter they were allowed to rest 
for the next 24-48 hours for observation. If, 
after this period there were no signs of improve­
ment or cure, the patients were removed to the 
nearest hospital as the diagnosis was then certainly 
not malaria.
The patients presenting with bizarre symptoms 
and signs were divided into five groups, according. V 
to the main presenting features when first seen.
Group I jj
Confusion and disorientation of sudden onset and b/ 
short duration. Seventeen cases were seen and outn'n 
of these 12 cases were confirmed as acute malaria ** If 
and cured after the single dose therapy.
Group II
Acute diarrhoea either with mucus or blood. 
Forty-seven cases were seen and 13 cases con­
firmed as dysenteric malaria.
Group III
Mild fever, headaches and body pains. Twenty- 
seven cases seen and 10 cases confirmed as acute 
malaria.
Group IV
Indicative of acute respiratory pathology. Seven­
teen cases seen and 6 cases confirmed as malaria. 
Group V
Presented with acute abdomen pathology. Seven­
teen cases seen and 4 cases only confirmed and 
cured of maiaria.
I f the single therapeutic dose cured the patient 
in 48-72 hours, then it was recorded as malaria 
positive. The initial pre-treatment thick and thin 
smears were later confirmed by a specialist 
malariologist as acute P. falciparum malaria. The 
confirmation strengthened the original accepted 
clinical cure.
In this initial single dose therapeutic trial, 
differences in sex, racial groups and patient’s 
weights were not recorded. Only adult patients 
were included in the trial. Any minor differences 
on the above parameters were not taken into 
consideration in this study, because I felt that in 
a first small test these differences would not be 
of statistical importance.
Total No. Positive Other
Cases Malaria Conditions
Group I 17 12 5
Group II 47 13 34
Group III 27 10 17
Group IV 17 6 11
Group V 17 4 13
125 45 80
Group 1 (17 Cases')
Clinical presentation: acute psychotic and con- 
fusional manifestations with disorientations or 
even mania.
Four of these cases presented with meningis- 
mus. Cerebral malaria in Africans in endemic 
areas is rare. The above presentation was asso­
ciated with, or initially thought to be, acute 
alcoholism or dagga smoking.
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24-48 hours after the initial single dose, 12 
cases were compltely cured. The remaining 5 were 
transferred to hospital and diagnosed as menin­
gococcal meningitis or encephalitis.
Group I I  (47 cases)
Clinical presentation: watery (greenish-yellow) 
diarrhoea with mucus and a little blood, or a 
frank bloody diarrhoea. Initially thought to be 
> acute bacillary dysentry or acute amoebic enter­
itis.
1 48 hours after initial screening by single dose
Bactrim as the only therapy, 13 cases were cured 
and confirmed as dysentric falciparum malaria.
The remaining 34 cases were later confirmed 
as other conditions on transfer to hospital, viz., 
typhoid fever and amoebic hepatitis.
Group I I I  (27 cases)
In this group the presentation is complex and 
is suggestive of influenza, with general muscle 
pains and spasms, cramps in limbs, weakness, and 
backache in most cases, or an erythematous 
urticaria and headaches. The temperature is either 
normal or slightly raised (99 or 100). The skin 
is hot and dry and in three cases there was some 
cyanosis of the extremities. In a few cases the 
only presentation' was a myalgia and arthralgia 
with some sensory clouding.
In endemic areas it is always essential to ex­
clude malaria before making the diagnosis of 
heatstroke; or any of the short-term fevers, viz., 
dengue and sandfly (Phlebotomus) fever are 
most typical. Forty-eight hours after the single 
dose, 10 cases were completely cured and smears 
confirmed P. falciparum infection.
The remaining cases, after removal to hospital, 
were confirmed as tick typhus, undulant fever, 
trypanosomiasis, and even of heatstroke. Malarial 
pyrexia is clinically, indistinguishable from heat 
pyrexia.
Group IV  (17 cases)
Presenting symptoms are: unproductive cough, 
occasionally associated with a small haemoptysis 
and chest pain, pleural pain and basilar rales. 
This respiratory presentation is difficult to diffe­
rentiate from bronchial or cavitating tuberculosis, 
ulcerative endocarditis or liver abscess.
Of these cases six were confirmed as malarial 
infection; . two associated with splenic infarcts; 
three other cases were active tuberculosis; a few 
cases were basal bronchopneumonia, but one case 
was a primary atypical pneumonia difficult to 
diagnose as some patients develop pneumoriia 
simultaneously with the acute attack of malaria, 
while others develop a secondary pneumonia.
Group V (17 cases)
Here the presentation was periumbilical or 
lower abdominal pain, associated with nausea and 
some vomiting or colic, suggesting the passage of 
gall stones or renal stones. This surgical abdomi­
nal presentation may readily be mistaken for 
appendicitis, acute cholecystitis or pancreatitis, 
especially if associated with jaundice.
The vomiting may be persistent and contain 
bile and often coffee grounds or unchanged 
blood, suggesting a form of malarial bilious re­
mittent fever. In all the cases the 10 tablets 
Bactrim were administered orally, associated with 
intramuscular antiemetics. Four cases were 
proven malaria.
The remaining cases were pyelitis, hepalitis and 
one case of perirenal abscess.
D iscussion
Single dose treatment of acute Falciparum 
malaria is desirable and advantageous,- especially 
in Africa where the best time to achieve any re­
sults of note is to administer the therapy com­
pletely at the time of consultation.
In all, 125 outpatients with tropical fevers were 
treated by random non-selection with Bactrim. In 
48 hours by single dose diagnostic therapy 45 
patients were confirmed as malaria and classed 
as cured. Unfortunately, it was not possible for 
any accurate lengthy followup for recurrences, 
■but a positive observation was that relapses seemed 
to be absent in the treated cases that were possible 
to follow for some weeks. The 45 cures suffered 
little morbidity and nil mortality. Knowledge 
about malaria acquired from the management of 
the afflicted non-immune soldiers in Vietnam had 
reduced the total case fatality rate to 0,3 per 
cent, (©lount, 1967). The method I have tried 
and put forward may offer 10 per cent, cures 
and nil mortality but would require a more .ex­
tensive trial in various areas, especially in manage­
ment of chloroquine-resistant Falciparum malaria 
and long-term environment follow-up.
The effectiveness Of TM  and SMZ combination 
is evident from the fact that 45 cases of pernicious 
malaria were cured in 48 hours. Good results 
with Bactrim, although in a different management 
method, have been reported by others (Wolfens- 
berger, 1970).
The dosage used in this trial exceeded the maxi­
mum recommended dosage (Roche) and may 
have been greater than required for the excellent 
clinical response, but patients may deteriorate 
rapidly with P. Falciparum malaria, especially the 
pernicious presentations, so an urgent diagnostic 
and radical therapeutic regimen was necessary. 
The rapid absorption of highly diffusible TM and 
SMZ and speedy action was observed in all cases.
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Numerous confirmations of this effect have been 
reported (Herrero, 1967). Studies with other 
drug combinations (Chin et al. 1966) reported 
slow action in termination of clinical attack. Speed 
of action was the most important consideration 
of the drug combination in clearing parasitaemia, 
especially where inoipient coma may be imminent 
(Woodruff, 1968).
Effective anti-malarial drugs must rapidly enter 
the red blood cells in sufficiently high concen­
trations to act against the erythrocytic schizonts. 
The sulphonamide (SMZ) presumably acts as a 
competitor of para-aminobenzoic acid in the 
synthesis of folic acid. SMZ combined with TM 
' gives high plasma levels and localisation in red 
cells, resulting in its rapid effective clearing of 
parasitaemia and lysis of fever.
Trimethoprim is rapidly absorbed completely 
and has a relatively short half-life, only 14 hours. 
This was important, for the diagnostic results of 
the therapy were required rapidly. SMZ almost 
has the same half-life, about 11 hours, with some 
50 per cent, of the drug bound to plasma proteins. 
In the dosage used in this trial clinical adverse 
reactions, in the form of gastro-intestinal distress, 
were seen in a few patients, but since most of 
the patients presenting prior to treatment already 
had nausea, the therapy was not contra-indicated. 
Nausea and vomiting are occasionally major prob­
lems in malaria management. If present, I fol­
lowed the programme of splitting the loading 
dose into three or five portions and each portion 
was given at 20 minute intervals as recommended 
by Jopling (1968).
In anti-malarial management, low drug toxicity 
is of paramount importance. At the dosage found 
effective, viz., TM and SMZ in the ratio 1:5, 
there was no reduction of RBC, WBC or platelet 
count (Hunsicker 1969). Comparing the side- 
effects of all the drugs used in the chemotherapy 
of malaria (L. Meyler, 1968), the TM and SMZ 
combination is the least toxic. Most of the side- 
effects of the anti-malarial drugs are common, 
with a variable incidence. However, with Bactrim 
the tolerance is high, and toxic side-effects few. 
Various blood dyscrasias and skin rashes have 
been observed (1968). Greying and bleaohing of 
the hair, and abnormal pigmentations after anti- 
malarial drugs have been described (Tuffanelli, 
1963), but in the 125 cases in this trial, no toxic 
effects were observed.
Resistance may develop when one or both 
members of the combination therapy are found in 
a' low concentration in the host early on in the 
clinical attack. The TM/SMZ combination in the 
single dose therapy that I have tried results in 
extremely high plasma and RBC levels within a 
short time after administration. This early high
concentration and rapid complete olearing of the 
parasitaemia provided the major factor in the 
excellent results achieved. The recrudescences af­
ter only 24 hours therapy, reported in a 12 case 
series by letter to the Editor by Clyde, D. F. 
(July, 1969), were probably due to inadequate 
host concentrations of combination drugs.
Trimethoprim plus SMZ clears the parasitaemia 
in a significantly shorter, time than any other drug 
combination (Dunno, 1969). To date resistance 
of the plasmodia to trimethoprim has not been 
demonstrated.
Thus I would like to recommend the use of 
BACTRIM (ROCHE) as the ideal drug for the 
wide-scale use in acute P. Falciparum malaria in 
Africa.
Sum m ary
Combined therapy with a single dose of sulpha- 
methoxazole (SMZ) and trimethoprim (TM), as 
BACTRIM (ROCHE), was found to be effective 
alone for the treatment of Plasmodium falcipa­
rum infection. The TM and SMZ therapy was 
100 per cent, effective in control of the clinical 
disease, without any recrudescences. This com­
bined therapy is suggested as the ideal anti- 
malarial drug; as the trial shows this therapy is 
the least toxic and unlikely to result in the de­
velopment of any resistant strains of P. Falci­
parum malaria.
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